144 related articles for article (PubMed ID: 16794287)
1. US study suggests universal vaccination of children with pneumococcal conjugate vaccine is beneficial for adults.
Doroshenko A
Euro Surveill; 2005 Nov; 10(11):E051124.4. PubMed ID: 16794287
[No Abstract] [Full Text] [Related]
2. HHS-CDC news: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--US, 1998-2003.
Ann Pharmacother; 2005 Nov; 39(11):1967-8. PubMed ID: 16219891
[No Abstract] [Full Text] [Related]
3. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
[TBL] [Abstract][Full Text] [Related]
4. Introduction of pneumococcal conjugate vaccine into the Norwegian childhood vaccination programme.
Bergsaker MA; Feiring B
Euro Surveill; 2006 Feb; 11(2):E060202.5. PubMed ID: 16804205
[No Abstract] [Full Text] [Related]
5. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.
Lexau CA; Lynfield R; Danila R; Pilishvili T; Facklam R; Farley MM; Harrison LH; Schaffner W; Reingold A; Bennett NM; Hadler J; Cieslak PR; Whitney CG;
JAMA; 2005 Oct; 294(16):2043-51. PubMed ID: 16249418
[TBL] [Abstract][Full Text] [Related]
6. Declining invasive pneumococcal disease in the U.S. elderly.
McBean AM; Park YT; Caldwell D; Yu X
Vaccine; 2005 Dec; 23(48-49):5641-5. PubMed ID: 16111788
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
[TBL] [Abstract][Full Text] [Related]
8. Prevnar--will it be the next vaccine success story?
Fiechtner HB
S D J Med; 2003 Sep; 56(9):377-8. PubMed ID: 14524137
[No Abstract] [Full Text] [Related]
9. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine.
Poehling KA; Szilagyi PG; Grijalva CG; Martin SW; LaFleur B; Mitchel E; Barth RD; Nuorti JP; Griffin MR
Pediatrics; 2007 Apr; 119(4):707-15. PubMed ID: 17403841
[TBL] [Abstract][Full Text] [Related]
10. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
Long SS
Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
[No Abstract] [Full Text] [Related]
11. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Advisory Committee on Immunization Practices
MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
[TBL] [Abstract][Full Text] [Related]
12. Direct, indirect and total effects of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children in Navarra, Spain, 2001 to 2014: cohort and case-control study.
Guevara M; Barricarte A; Torroba L; Herranz M; Gil-Setas A; Gil F; Bernaola E; Ezpeleta C; Castilla J;
Euro Surveill; 2016; 21(14):. PubMed ID: 27103428
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
[TBL] [Abstract][Full Text] [Related]
14. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
[TBL] [Abstract][Full Text] [Related]
15. [Time to vaccinate infants and small children against pneumococci].
Silfverdal SA; Gothefors L
Lakartidningen; 2006 Feb 15-21; 103(7):477-8. PubMed ID: 16535879
[No Abstract] [Full Text] [Related]
16. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
Rose M; Zielen S
Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
[TBL] [Abstract][Full Text] [Related]
17. The heptavalent conjugate pneumococcal vaccine and its implications for managed care--clinical overview and roundtable discussions.
Alexander PG; Chartrand SA; Davies TJ; Gaines BM; Oster G; Shurin P; Tamsky L; Thornton DK; Wittert W
Manag Care Interface; 2001; Suppl C():10-28; quiz 29-30. PubMed ID: 11724029
[No Abstract] [Full Text] [Related]
18. Risk groups and uptake of influenza and pneumococcal vaccine in Ireland.
Mereckiene J; O'Donnell J; Collins C; Cotter S; Igoe D; O'Flanagan D
Euro Surveill; 2007 Dec; 12(12):E13-4. PubMed ID: 18076858
[TBL] [Abstract][Full Text] [Related]
19. Introduction of pneumococcal conjugate vaccine to the UK childhood immunisation programme, and changes to the meningitis C and Hib schedules.
Cameron C; Pebody R
Euro Surveill; 2006 Mar; 11(3):E060302.4. PubMed ID: 16804223
[No Abstract] [Full Text] [Related]
20. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
Haveman LM; Geelen SP; Sanders EA; Wolfs TF
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
